Education Library

Federico Pappalardo, MD, describes the role of IABP in the treatment of acute-on-chronic heart failure complicated by cardiogenic shock. 

Mario Iannaccone, MD and Vasileios Panoulas, MD, discuss two meta-analyses demonstrating improved survival in cardiogenic shock managed with ECMO and Impella (ECpella™) versus ECMO alone.

Charles Simonton, MD, interviews Prof. Norman Mangner, MD, from Dresden Heart Center, about the rollout of the PROTECT IV trial. The interview focuses on an update on the PROTECT IV trial in light of the upcoming Investigator Meeting at the EuroPCR in Paris in May 2022.

The focus of the interview between Charles Simonton, MD, and PD Fadi Al-Rashid, MD, is an update on the STEMI DTU trial in light of the investigator meeting at EuroPCR in Paris in May 2022.

Dr. Mario Iannaccone is interviewed on "Comparison of ECMO vs ECpella in patients with non post-pericardiotomy cardiogenic shock: An updated meta-analysis".

Dr. Mario Iannaccone is interviewed on "Short term outcomes of Impella® circulatory support for high-risk percutaneous coronary intervention a systematic review and meta-analysis".

Dr. Alaide Chieffo on the views of an expert panel and appraises the value of short-term pVAD.

Updates on transient mechanical circulatory support in cardiogenic shock

EuroPCR 2021: Sharing knowledge, skills, and experience. In the digital symposium by ABIOMED you will learn all about the importance of extensive…

ICU management of Impella patients can be challenging. The growing need for guidance in patient selection, therapy strategies, escalation and weaning led a group of experts to the publication of a European Heart Journal supplement with 8 individual manus.

STATUS QUO 2020: what have we learned so far in temporary mechanical circulatory support? Use of Impella beyond the cathlab: open issues and clinical…

This is the largest European series of patients with Impella support demonstrating real-life data about Impella usage during the last years.

Learn more about Dr. Jörn Tongers presentation on "ECpella - Who, when & how " at virtual JIM congress.

The IMP-IT study is a national multicenter retrospective observational registry and 406 consecutive patients, treated with Impella® were …

Discover our symposium at E-JESFC "How to facilitate extensive revascularization in High Risk PCI using PMCS".…